Literature DB >> 20859162

Polypropylene vaginal mesh grafts in gynecology.

Donald R Ostergard1.   

Abstract

Basic concepts are presented for the use of polypropylene mesh in gynecology for prolapse and stress-incontinence repair. The vagina is a clean-contaminated environment, and it is not possible to insert polypropylene mesh devices without bacterial contamination, despite standard antibiotic usage. Once inserted, the host tissue immediately attaches to the polypropylene and attempts to defend it from bacterial invasion, but if the bacteria have already reached the surface of the device, then dislodgement is difficult. The devices with larger surface areas result in greater bacterial contamination, more polypropylene degradation, increased inflammatory response, fibrous tissue stimulation, and erosion. Noninert polypropylene degrades into potentially toxic compounds that would be expected to stimulate a greater inflammatory reaction leading to erosion. If the physician does not place the mesh below full-thickness vaginal epithelium, penetrates the epithelium during insertion, or if there is hematoma formation near the vaginal incision, then defective healing and erosion may result. Scar tissue causes contraction to less than 50% of the implanted size, which results in dyspareunia and tension on the pelvic mesh attachments. Such contraction may cause pelvic pain and subsequent erosion into adjacent organs. An individual response in fibrosis also exists, with some individuals being "high responders." Manufacturers need encouragement to develop meshes that are inert and incorporate without contraction along with routine clinical tests to detect "high responders" to avoid complications. Polypropylene is not inert within the human body.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20859162     DOI: 10.1097/AOG.0b013e3181f39b20

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  11 in total

1.  Computer modeling informs study design: vaginal estrogen to prevent mesh erosion after different routes of prolapse surgery.

Authors:  Alison C Weidner; Jennifer M Wu; Amie Kawasaki; Evan R Myers
Journal:  Int Urogynecol J       Date:  2012-07-17       Impact factor: 2.894

Review 2.  Is pain relief after vaginal mesh and/or sling removal durable long term?

Authors:  Karen Jong; Shreeya Popat; Alana Christie; Philippe E Zimmern
Journal:  Int Urogynecol J       Date:  2017-07-10       Impact factor: 2.894

3.  Prospective study of an ultra-lightweight polypropylene Y mesh for robotic sacrocolpopexy.

Authors:  Charbel G Salamon; Christa Lewis; Jennifer Priestley; Emil Gurshumov; Patrick J Culligan
Journal:  Int Urogynecol J       Date:  2013-01-08       Impact factor: 2.894

Review 4.  Clinical application of 2D and 3D pelvic floor ultrasound of mid-urethral slings and vaginal wall mesh.

Authors:  Annika Taithongchai; Abdul H Sultan; Pawel A Wieczorek; Ranee Thakar
Journal:  Int Urogynecol J       Date:  2019-05-11       Impact factor: 2.894

5.  Mesh retraction correlates with vaginal pain and overactive bladder symptoms after anterior vaginal mesh repair.

Authors:  A Rogowski; P Bienkowski; A Tosiak; M Jerzak; P Mierzejewski; W Baranowski
Journal:  Int Urogynecol J       Date:  2013-06-08       Impact factor: 2.894

6.  Hernia repair with polypropylene mesh is not associated with an increased risk of autoimmune disease in adult men.

Authors:  B Chughtai; D Thomas; J Mao; K Eilber; J Anger; J Q Clemens; A Sedrakyan
Journal:  Hernia       Date:  2017-02-23       Impact factor: 4.739

Review 7.  Polypropylene mesh and systemic side effects in inguinal hernia repair: current evidence.

Authors:  Cillian Clancy; Patrick Jordan; Paul F Ridgway
Journal:  Ir J Med Sci       Date:  2019-03-27       Impact factor: 1.568

8.  Prospective ultrasonographic follow-up of transvaginal lightweight meshes: a 1-year multicenter study.

Authors:  Lucie Allègre; Geertje Callewaert; Charles Coudray; Christophe Demattei; Laure Panel; Caroline Carlier-Guerin; Vincent Letouzey; Renaud de Tayrac; Brigitte Fatton
Journal:  Int Urogynecol J       Date:  2020-08-17       Impact factor: 2.894

Review 9.  Transvaginal retropubic sling systems: efficacy and patient acceptability.

Authors:  Christina P Moldovan; Michelle E Marinone; Andrea Staack
Journal:  Int J Womens Health       Date:  2015-02-16

Review 10.  Are polypropylene mesh implants associated with systemic autoimmune inflammatory syndromes? A systematic review.

Authors:  C R Kowalik; S E Zwolsman; A Malekzadeh; R M H Roumen; W A R Zwaans; J W P R Roovers
Journal:  Hernia       Date:  2022-01-12       Impact factor: 2.920

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.